Detectable Neuropsychological Differences in Early Preclinical Alzheimer’s Disease: A Meta-Analysis

Clinically Different Stages of Alzheimer's Disease Associated by Amyloid Deposition with [11C]-PIB PET Imaging

(2017) Shizuo Hatashita et al.   JOURNAL OF ALZHEIMERS DISEASE

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

(2016) Bruno Dubois et al.   Alzheimers & Dementia

Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease

(2016) Rachel F. Buckley et al.   Alzheimers & Dementia

Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease

(2016) Andrei G. Vlassenko et al.   ANNALS OF NEUROLOGY

Practice effects and longitudinal cognitive change in clinically normal older adults differ by Alzheimer imaging biomarker status

(2016) Mary M. Machulda et al.   CLINICAL NEUROPSYCHOLOGIST

Amyloid burden and incident depressive symptoms in cognitively normal older adults

(2016) Karra D. Harrington et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

 -Amyloid Deposition Is Associated with Decreased Right Prefrontal Activation during Task Switching among Cognitively Normal Elderly

(2016) H. Oh et al.   JOURNAL OF NEUROSCIENCE

Certified normal: Alzheimer's disease biomarkers and normative estimates of cognitive functioning

(2016) Jason Hassenstab et al.   NEUROBIOLOGY OF AGING

NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers

(2016) Stephanie J.B. Vos et al.   NEUROBIOLOGY OF AGING

Myo-inositol changes precede amyloid pathology and relate toAPOEgenotype in Alzheimer disease

(2016) Olga Voevodskaya et al.   NEUROLOGY

Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

(2016) Y. Iturria-Medina et al.   Nature Communications

Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change

(2016) Anja Soldan et al.   JAMA Neurology

Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community

(2016) Ronald C. Petersen et al.   JAMA Neurology

Amyloid β oligomers in Alzheimer’s disease pathogenesis, treatment, and diagnosis

(2015) Kirsten L. Viola et al.   ACTA NEUROPATHOLOGICA

Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly

(2015) Prashanthi Vemuri et al.   BRAIN

The preclinical phase of the pathological process underlying sporadic Alzheimer’s disease

(2015) Heiko Braak et al.   BRAIN

Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia

(2015) Willemijn J. Jansen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Neuropsychological Markers of Cognitive Decline in Persons With Alzheimer Disease Neuropathology

(2015) Jason Hassenstab et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer's Disease

(2015) F. L. Besson et al.   JOURNAL OF NEUROSCIENCE

Improved Power for Characterizing Longitudinal Amyloid-  PET Changes and Evaluating Amyloid-Modifying Treatments with a Cerebral White Matter Reference Region

(2015) K. Chen et al.   JOURNAL OF NUCLEAR MEDICINE

Regional cerebral blood flow estimated by early PiB uptake is reduced in mild cognitive impairment and associated with age in an amyloid-dependent manner

(2015) Anton F. Gietl et al.   NEUROBIOLOGY OF AGING

Disruption of cholinergic neurotransmission exacerbates Aβ-related cognitive impairment in preclinical Alzheimer's disease

(2015) Yen Ying Lim et al.   NEUROBIOLOGY OF AGING

Increased levels of plasma amyloid-beta are related to cortical thinning and cognitive decline in cognitively normal elderly subjects

(2015) Sandra Llado-Saz et al.   NEUROBIOLOGY OF AGING

Aβ-related hyperactivation in frontoparietal control regions in cognitively normal elderly

(2015) Hwamee Oh et al.   NEUROBIOLOGY OF AGING

Subjective cognitive concerns, amyloid-β, and neurodegeneration in clinically normal elderly

(2015) Rebecca E. Amariglio et al.   NEUROLOGY

Cognitive activity relates to cognitive performance but not to Alzheimer disease biomarkers

(2015) Christopher M. Gidicsin et al.   NEUROLOGY

Spectrum of cognition short of dementia

(2015) David S. Knopman et al.   NEUROLOGY

Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease

(2015) Daniel Alcolea et al.   NEUROLOGY

Amyloid-Related Memory Decline in Preclinical Alzheimer’s Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months

(2015) Christine Thai et al.   PLoS One

Practice Effects and Amyloid Deposition

(2014) Kevin Duff et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease

(2014) Jessica B. Langbaum et al.   Alzheimers & Dementia

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

(2014) Frank Jessen et al.   Alzheimers & Dementia

Regional amyloid burden and intrinsic connectivity networks in cognitively normal elderly subjects

(2014) Hyun Kook Lim et al.   BRAIN

The Alzheimer’s Prevention Initiative Composite Cognitive Test Score

(2014) Napatkamon Ayutyanont et al.   JOURNAL OF CLINICAL PSYCHIATRY

Amyloid Deposition Is Linked to Aberrant Entorhinal Activity among Cognitively Normal Older Adults

(2014) W. Huijbers et al.   JOURNAL OF NEUROSCIENCE

Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50–89 years: a cross-sectional study

(2014) Clifford R Jack et al.   LANCET NEUROLOGY

Florbetapir F 18 amyloid PET and 36-month cognitive decline:a prospective multicenter study

(2014) P M Doraiswamy et al.   MOLECULAR PSYCHIATRY

Neural compensation in older people with brain amyloid-β deposition

(2014) Jeremy A Elman et al.   NATURE NEUROSCIENCE

White matter changes in preclinical Alzheimer's disease: a magnetic resonance imaging-diffusion tensor imaging study on cognitively normal older people with positive amyloid β protein 42 levels

(2014) José Luis Molinuevo et al.   NEUROBIOLOGY OF AGING

Cortical thickness mediates the effect of  -amyloid on episodic memory

(2014) S. Villeneuve et al.   NEUROLOGY

The Preclinical Alzheimer Cognitive Composite

(2014) Michael C. Donohue et al.   JAMA Neurology

The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly

(2013) Miranka Wirth et al.   Alzheimers & Dementia

Is Verbal Episodic Memory in Elderly with Amyloid Deposits Preserved Through Altered Neuronal Function?

(2013) Rik Ossenkoppele et al.   CEREBRAL CORTEX

Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study

(2013) Stephanie JB Vos et al.   LANCET NEUROLOGY

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

(2013) Clifford R Jack et al.   LANCET NEUROLOGY

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

(2013) Victor L Villemagne et al.   LANCET NEUROLOGY

Cognitive trajectories associated with  -amyloid deposition in the oldest-old without dementia

(2013) B. E. Snitz et al.   NEUROLOGY

Meta-analysis of amyloid-cognition relations in cognitively normal older adults

(2013) T. Hedden et al.   NEUROLOGY

Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity

(2013) C. R. Jack et al.   NEUROLOGY

Preclinical Alzheimer disease and risk of falls

(2013) S. L. Stark et al.   NEUROLOGY

The Aging Brain and Cognition

(2013) Natalie L. Marchant et al.   JAMA Neurology

In vivo assessment of amyloid-β deposition in nondemented very elderly subjects

(2012) Chester A. Mathis et al.   ANNALS OF NEUROLOGY

Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

(2012) Peter T. Nelson et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Effects of age and β-amyloid on cognitive changes in normal elderly people

(2012) Hwamee Oh et al.   NEUROBIOLOGY OF AGING

Amyloid deposition detected with florbetapir F 18 (18F-AV-45) is related to lower episodic memory performance in clinically normal older individuals

(2012) Reisa A. Sperling et al.   NEUROBIOLOGY OF AGING

A computational neurodegenerative disease progression score: Method and results with the Alzheimer's disease neuroimaging initiative cohort

(2012) Bruno M. Jedynak et al.   NEUROIMAGE

Accelerated cortical atrophy in cognitively normal elderly with high  -amyloid deposition

(2012) G. Chetelat et al.   NEUROLOGY

Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease

(2012) D. S. Knopman et al.   NEUROLOGY

Amyloid-  assessed by florbetapir F 18 PET and 18-month cognitive decline: A multicenter study

(2012) P. M. Doraiswamy et al.   NEUROLOGY

Subjective cognitive complaints and amyloid burden in cognitively normal older individuals

(2012) Rebecca E. Amariglio et al.   NEUROPSYCHOLOGIA

Enrichment and Stratification for Predementia Alzheimer Disease Clinical Trials

(2012) Dominic Holland et al.   PLoS One

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Reisa A. Sperling et al.   Alzheimers & Dementia

An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease

(2011) Clifford R. Jack et al.   ANNALS OF NEUROLOGY

Cognitively Preserved Subjects with Transitional Cerebrospinal Fluid ß-Amyloid 1-42 Values Have Thicker Cortex in Alzheimer's Disease Vulnerable Areas

(2011) Juan Fortea et al.   BIOLOGICAL PSYCHIATRY

Not quite PIB-positive, not quite PIB-negative: Slight PIB elevations in elderly normal control subjects are biologically relevant

(2011) Elizabeth C. Mormino et al.   NEUROIMAGE

Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study

(2011) Kerryn E. Pike et al.   NEUROPSYCHOLOGIA

Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1-42

(2010) Jonathan M. Schott et al.   ANNALS OF NEUROLOGY

Larger temporal volume in elderly with high versus low beta-amyloid deposition

(2010) Gaël Chételat et al.   BRAIN

β-Amyloid affects frontal and posterior brain networks in normal aging

(2010) Hwamee Oh et al.   NEUROIMAGE

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

(2009) Clifford R Jack et al.   LANCET NEUROLOGY

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

(2009) Alessandro Liberati et al.   PLOS MEDICINE

Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly

(2008) Howard Jay Aizenstein et al.   ARCHIVES OF NEUROLOGY

Appearance modeling of 11C PiB PET images: Characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging

(2008) Jurgen Fripp et al.   NEUROIMAGE